An Other Transaction (OT) Agreement is a streamlined purchasing vehicle that brings innovative research findings and state-of-the-art prototypes from industry to the federal government. OT-based collaborations are not subject to some of the regulations that apply to Federal Acquisition Regulation (FAR)-based acquisitions. OTs enable fast acquisition of critically-needed technologies.
- BARDA uses OTs to further its advanced research and development goals, promote innovation, and support the mission of the HHS Public Health Emergency Medical Countermeasures Enterprise
- BARDA uses OTs as a type of flexible, strategic partnership between the government and industry to foster innovation and promote collaboration
- The OT-based consortium model allows government and industry to communicate more openly, from requirement generation to the proposal stage
- OTs affords greater technology and prototype acquisition speed, getting solutions to end users sooner
- OTs emphasizes engaging a diverse range of technology suppliers of all sizes, casting a wider net for capturing ideas and innovations
- OTs enable faster contracting through long-term agreements between industry and Government that establish baseline terms and conditions (with the flexibility for negotiated modifications on a project-by-project basis)
The OT authority consortium enterprise is good government in action—the competition it promotes between large, traditional R&D providers, academic institutions, and small and nontraditional suppliers drives innovation across the entire US economy.
Open Communications = More Relevant Technology Solutions
The OT-based consortium model allows government and industry to communicate more openly from requirement generation to the proposal stage; it affords greater technology and prototype acquisition speed, getting solutions to end-users sooner; and it emphasizes engaging a diverse range of technology suppliers by casting a wider net for capturing ideas and innovations.
View frequently asked questions and learn more about joining the BioMaP-Consortium.